Outset Medical (OM) Cost of Revenue (2019 - 2026)

Outset Medical (OM) has reported Cost of Revenue for 8 consecutive years, with $18.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cost of Revenue fell 6.13% year-over-year to $18.4 million in Q2 2026; TTM through Jun 2026 was $68.6 million, a 9.5% decrease from a year earlier, with the FY2025 full-year figure at $72.7 million, down 3.2% from the prior year.
• Cost of Revenue was $18.4 million for Q2 2026 at Outset Medical, up from $15.8 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $28.3 million in Q2 2023 and troughed at $15.8 million in Q1 2026.
• A 5-year average of $21.2 million and a median of $19.8 million in 2024 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue surged 33.19% in 2023 and slumped 37.87% in 2024, its largest moves.
• Over 5 years, Cost of Revenue stood at $26.7 million in 2022, then slipped by 14.73% to $22.8 million in 2023, then fell by 17.88% to $18.7 million in 2024, then fell by 11.1% to $16.6 million in 2025, then advanced by 10.27% to $18.4 million in 2026.
• The last three Cost of Revenue figures came in at $18.4 million (Q2 2026), $15.8 million (Q1 2026), and $16.6 million (Q4 2025), per Business Quant data.